Dr Rebecca Feltham
Honorary (Fellow)
Department of Medical Biology (WEHI)
41 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
The benchmarking and application of tag-degraders in vivo to validate therapeutic targets
DOI: 10.1038/s41467-026-73681-12026
Journal article
Efferocytosis of apoptotic bodies drives SARS-CoV-2 infection and macrophage inflammation
DOI: 10.1038/s41467-026-74363-82026
Journal article
ANCHR regulates TRAIL-mediated apoptosis with implications for liver injury
DOI: 10.1016/j.heliyon.2026.e450902026
Journal article
Global analysis of cancer cell responses to USP9X inhibition
DOI: 10.1038/s44318-026-00742-y2026
Journal article
The E3-ome gene-centric compendium reveals the human E3 ligase landscape
DOI: 10.1016/j.cell.2026.01.0292026
Journal article
A TAK1 cytokine toxicity checkpoint controls anti-cancer immunity
DOI: 10.1016/j.celrep.2025.1166652020
Journal article
An Erg-driven transcriptional program controls B cell lymphopoiesis.
DOI: 10.1038/s41467-020-16828-y
RECENT SCHOLARLY WORKS
2024
Journal article
Correction to: RIPK1 prevents TRADD-driven, but TNFR1 independent, apoptosis during development (Cell Death & Differentiation, (2019), 26, 5, (877-889), 10.1038/s41418-018-0166-8)
DOI: 10.1038/s41418-024-01401-72024
Journal article
Mind bomb 2 limits inflammatory dermatitis in Sharpin mutant mice independently of cell death
DOI: 10.1093/pnasnexus/pgad4382023
Journal article
Author Correction: Discovery of an exosite on the SOCS2-SH2 domain that enhances SH2 binding to phosphorylated ligands (Nature Communications, (2021), 12, 1, (7032), 10.1038/s41467-021-26983-5)
DOI: 10.1038/s41467-023-42706-42023
Journal article
Design and characterization of a heterobifunctional degrader of KEAP1
DOI: 10.1016/j.redox.2022.102552